Ivanova, E.,
Gilyazova, I.,
Pavlov, V.,
Izmailov, A.,
Gimalova, G.,
Karunas, A.,
Prokopenko, I.,
Khusnutdinova, E. (2022) individuals without the disease. Individual
genetic risks were defined using the SNP-variant effects derived
in discovering new
genetic loci associated with hypertension and related traits. However, identifying informative
Solovyev, A.V.,
Dzhemileva, L.U.,
Posukh, O.L.,
Barashkov, N.A.,
Bady-Khoo, M.S.,
Lobov, S.L.,
Popova, N.Y.,
Romanov, G.P.,
Sazonov, N.N.,
Bondar, A.A.,
Morozov, I.V.,
Tomsky, M.I.,
Fedorova, S.A.,
Khusnutdinova, E.K. (2017) sensory disorder. The
results of the molecular-based studies of HI are widely used
in various
genetic test
Gareeva, A.E.,
Sharafiev, R.R.,
Akhmetova, E.A.,
Nasibullin, T.R.,
Fakhurtdinova, Z.R.,
Yuldashev, V.L.,
Asadullin, A.R. (2020) cannabinoids taking account of the combined influences of
genetic predisposition and attention deficit hypera
Timasheva, Y,
Nasibullin, TR,
Tuktarova, IA,
Erdman, VV,
Galiullin, TR,
Zaplakhova, OV,
Bakhtiiarova, KZ (2022) .
Objective: Our aim was to identify
genetic predictors of multiple sclerosis in three ethnically homogenous